RF, W., PD, A., T, H., MI, G., G, W., M, M., & DH, C. (2005). Treatment of Epstein-Barr-virus-associated primary CNS B-cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation. Lancet Oncology, 6(5), 344. https://doi.org/10.1016/s1470-2045(05)70171-6
Chicago Style (17th ed.) CitationRF, Wynn, Arkwright PD, Haque T, Gharib MI, Wilkie G, Morton-Jones M, and Crawford DH. "Treatment of Epstein-Barr-virus-associated Primary CNS B-cell Lymphoma with Allogeneic T-cell Immunotherapy and Stem-cell Transplantation." Lancet Oncology 6, no. 5 (2005): 344. https://doi.org/10.1016/s1470-2045(05)70171-6.
MLA (9th ed.) CitationRF, Wynn, et al. "Treatment of Epstein-Barr-virus-associated Primary CNS B-cell Lymphoma with Allogeneic T-cell Immunotherapy and Stem-cell Transplantation." Lancet Oncology, vol. 6, no. 5, 2005, p. 344, https://doi.org/10.1016/s1470-2045(05)70171-6.